SAFETY AND EFFICACY STUDY OF LUMASIRAN, AN INVESTIGATIONAL RNA INTERFERENCE (RNAI) THERAPEUTIC, IN ADULT AND PEDIATRIC PATIENTS WITH PRIMARY HYPEROXALURIA TYPE 1 (PH1)

Frishberg, Y; Deschenes, G; Cochat, P; Magen, D; Groothoff, J; Hulton, SA; Harambat, J; Hoff, WV; Hoppe, B; Lieske, JC; McGregor, TL; Haslett, P; Talamudupula, S; Erbe, DV; Milliner, DS

JOURNAL OF UROLOGY, 2019; 201 (4): E174